Nextcure to present at the h.c. wainwright 25th annual global investment conference

Beltsville, md., aug. 31, 2023 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the h.c. wainwright 25th annual global investment conference in new york city on monday, september 11th, at 5:00 pm et.
NXTC Ratings Summary
NXTC Quant Ranking